MISION & VISION
BIOMAR Microbial Technologies is a biotech company founded in 1996, devoted to Marine Microbiology and Natural Products Chemistry
BIOMAR Microbial Technologies is a biotech company founded in 1996, devoted to Marine Microbiology and Natural Products Chemistry.
Marine biodiversity is assumed to be higher than terrestrial, although marine studies have been under represented for decades due to the technical difficulties in bioprospecting the ocean.
Our goal is to discover, develop and produce new compounds and products of industrial interest.
The company strategic vision relies in two fundamental concepts: INNOVATION AND SUSTAINABILITY.
We offer a unique combination of both products and services based on marine microorganisms and the compounds they produce.
The diversity of our libraries, our team technical excellence and our large experience in the design and performance of research projects, have been the basis of our success in the development of products and processes in three major industrial sectors: Human Health and Cosmetics, Agriculture and Food Industry.
MILESTONES
A beautiful journey full of discoveries
Inauguration of new production plant with capacity of up to 3000L.
Signing of a contract with a leading company in the pharmaceutical sector: animal health products
Recognition to the biopesticides strategic plan from Junta de Castilla y León
Product Development and Production Area transfer to 4D Pharma PLC.
Human Health reactivation. Adjustment of proceedings to Nagoya Protocol.
Extension of Valent BioSciences Corporation contract. Bio-rational products.
The company fulfils financial balance and profit
First Biomar's EPA approved product, herbicide Thaxtomin A.
Quality Standards and increment of production capacity to 3000 L
We are opening a new building in the León Technology Park.
Food additives, a new biotechnology sector.
Identification of Microalgae for biodiesel production.
First increase in company's share capital.
UE MIRACLE Project ISolation of uncultured marine microorganism.
First Spanish insdustrial microalgae library.
Human Health new therapeutic areas antiagiogenesis and neoroprotection.
Dr. Antonio Fernández appointed new CEO.
Production kick off the Fermentation Pilot Plant.
Agrilculture biopesticides, new biotech area. R&D contract with Dupont.
Human Health new therapeutic areas antifectives and oncology.
Human Health focused on Oftalmology. Colaboration with ONCE.
Beginning of marine bioprospections that will constitute Biomar Libraries.
Biomar arises as a spin off of PharmaMar (Grupo Zeltia).
MANAGEMENT
Dr. Antonio Fernández Medarde
Chief Executive Officer
CEO. Antonio got his PhD from the Univerisity of Texas, MD Anderson Cancer Center in Houston where he also did his postdoctoral studies in the Department of Cellular Biology and Molecular Pathology.
After that, he moved to Boston to work as a scientist under the supervision of Dr. Judah Folkman in the Department of Tumor Immunology at the Dana-Farber Cancer Institute and the Children’s Hospital of Boston Surgical Research Laboratories, both associated to Harvard Medical School.
In 2001, he moved back to Spain joining the Research Unit at Hospital de León until February 2002 when he became part of Biomar’s team.
DO YOU HAVE AN IDEA
WE
...LITERALLY
Biomar counts with 750 m2 fully dedicated to the development of GMP fermentation, with process capacity up to 3000 L. Our scientists’ extensive experience in developing bacterial, fungal and actinomycete fermentations, together with our brand new facilities, guarantee a comprehensive CDMO service. Our plant has all the necessary equipment for process development and optimisation, both upstream and downstream.

























